Skip to content

Editors

Harry20Cassin20Managing20Editor-229x300

Harry Cassin
Publisher and Editor

Screen+Shot+2017-02-14+at+1.01.41+PM

Andy Spalding
Senior Editor

Screen+Shot+2017-02-14+at+12.59.08+PM

Jessica Tillipman
Senior Editor

Screen+Shot+2017-02-14+at+1.16.41+PM

Richard L. Cassin
Editor at Large

Elizabeth K. Spahn

Elizabeth K. Spahn
Editor Emeritus

Screen+Shot+2017-02-14+at+6.33.34+AM-3

Cody Worthington
Contributing Editor

Screen+Shot+2017-02-14+at+12.28.51+PM

Julie DiMauro
Contributing Editor

Screen+Shot+2017-02-14+at+12.44.07+PM

Thomas Fox
Contributing Editor

Screen+Shot+2017-02-14+at+12.46.31+PM

Marc Alain Bohn
Contributing Editor

Screen+Shot+2017-02-14+at+12.33.28+PM

Bill Waite
Contributing Editor

Screen+Shot+2017-08-18+at+6.34.39+AM

Shruti J. Shah
Contributing Editor

Screen+Shot+2017-02-14+at+1.13.40+PM

Russell A. Stamets
Contributing Editor

Screen+Shot+2017-02-14+at+3.09.39+PM

Richard Bistrong
Contributing Editor

Screen+Shot+2017-02-14+at+12.49.07+PM

Eric Carlson
Contributing Editor

WILLIAM B.F. STEINMAN

Bill Steinman
Contributing Editor

DOJ joins Alexion FCPA investigation

Richard L. Cassin November 9, 2015

Image courtesy of AlexionAlexion Pharmaceuticals Inc. said in a securities filing that the Justice Department is now investigating the company’s grant-making activities and its compliance with the Foreign Corrupt Practices Act.… Continue Reading